RON
GELLER -
INVEST CONT DOCTOR POSTRYC UV
Centro Nacional de Biotecnología
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Centro Nacional de Biotecnología (5)
2024
-
Functional antibody responses targeting the Spike protein of SARS-CoV-2 Omicron XBB.1.5 in elderly nursing home residents following Wuhan-Hu-1-based mRNA booster vaccination
Scientific reports, Vol. 14, Núm. 1, pp. 11896
2023
-
Antibody-dependent NK-cell and neutralizing antibody responses against the Spike protein of Wuhan-Hu-1 and Omicron BA.1 SARS-CoV-2 variants in vaccinated experienced and vaccinated naïve individuals
Journal of medical virology, Vol. 95, Núm. 7, pp. e28900
-
C-2 Thiophenyl Tryptophan Trimers Inhibit Cellular Entry of SARS-CoV-2 through Interaction with the Viral Spike (S) Protein
Journal of Medicinal Chemistry, Vol. 66, Núm. 15, pp. 10432-10457
2022
-
Rapid and direct quantification of the SARS-CoV-2 virus with an ultrasensitive nanobody-based photonic nanosensor
Sensors and Diagnostics, Vol. 1, Núm. 5, pp. 983-993
-
The structural role of SARS-CoV-2 genetic background in the emergence and success of spike mutations: The case of the spike A222V mutation
PLoS Pathogens, Vol. 18, Núm. 7 July